ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Axsome Therapeutics, Inc. clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 37 studies whose lead sponsor is Axsome Therapeutics, Inc. 12 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 10, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Axsome Therapeutics with Eli Lilly and Neurocrine Biosciences →

Pipeline: 3 programs

Each counted once: 3 with a study Axsome Therapeutics, Inc. leads registered in the last two years.

  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Axsome Therapeutics, Inc.’s own registered studies; Axsome Therapeutics, Inc.’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Axsome Therapeutics, Inc.’s studies test, most open studies first — 7 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

2 of Axsome Therapeutics, Inc.’s studies under way reach primary completion within a year, all of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 2D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 37 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1232%Recruiting 9 · Enrolling by invitation 3
  • Completed2054%
  • Stopped early25%
  • Status unknown or other38%

Phase

  • Phase 328
  • Phase 26
  • Phase 42
  • Phase 11

Where

  • United States37
  • Canada7
  • Australia3
  • Puerto Rico3
  • United Kingdom2
  • Italy1

Over the years

  1. 15
  2. 16
  3. 17
  4. 18
  5. 719
  6. 20
  7. 21
  8. 22
  9. 23
  10. 24
  11. 25
  12. 726

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Axsome Therapeutics, Inc.

  • Axsome Therapeutics, Inc.
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    37 studies

Focus areas

Conditions Axsome Therapeutics, Inc. leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 37 of 37.